Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
Clinicians should monitor thyroid function tests (TSH, free T4) at: Baseline before starting weight loss injections 6-8 weeks after achieving maintenance dose Every 3-6 months during active weight loss After significant weight stabilization Symptoms of overreplacement (palpitations, anxiety, tremor, heat intolerance) should prompt earlier testing
The drug is indicated to treat type 2 diabetes
To view a copy of this licence, visit About this article Cite this article Wajdlich, M., Nowicki, M
Those who did not discontinue therapy achieved a 0.4 percentage point drop in HbA1c vs
Retatrutide has not been compared head-to-head with earlier GLP-1 medications in any clinical trials, although there is an ongoing trial called TRIUMPH-5, which is comparing it with tirzepatide
